Budget and health impact of switching eligible patients with atrial fibrillation to lower- dose dabigatran
- Tanja Fens*
- , Lisa de Jong
- , Bregt Kappelhoff
- , Cornelis Boersma
- , Maarten J. Postma
*Corresponding author for this work
Research output: Contribution to journal › Article › Academic › peer-review